Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Tai-Cherng Liou"'
Autor:
Ting-Wen Liu, Yen-Po Chen, Cheng-Yu Ho, Ming-Jen Chen, Horng-Yuan Wang, Shou-Chuan Shih, Tai-Cherng Liou
Publikováno v:
Biomedicines, Vol 11, Iss 4, p 1084 (2023)
Helicobacter pylori (H. pylori) can be eradicated immediately via local application of single-dose medicament on endoscopic examination. In our previous report, “the eradication rate of intraluminal therapy for H. pylori infection (ILTHPI) is 53.7%
Externí odkaz:
https://doaj.org/article/25e45276d1b14d77b03e4d6f37600f7e
Autor:
Cheng-Yu Ho, Ting-Wen Liu, Yang-Sheng Lin, Yen-Po Chen, Ming-Jen Chen, Horng-Yuan Wang, Tai-Cherng Liou
Publikováno v:
Microorganisms, Vol 10, Iss 2, p 415 (2022)
Helicobacter pylori (H. pylori) can be eradicated immediately while conducting an endoscopic examination. The eradication rate of intraluminal therapy for H. pylori infection (ILTHPI) is 53.7% (51/95) via local application of single-dose medicament c
Externí odkaz:
https://doaj.org/article/b584a75271ea402295470255b575b58c
Autor:
Ching-Chung Lin, Ming-Jong Bair, Chih-Jen Chen, Keng-Han Lee, Ming-Jen Chen, Chia-Yuan Liu, Chen-Wang Chang, Kuang-Chun Hu, Tai-Cherng Liou, Shee-Chan Lin, Horng-Yuan Wang, Cheng-Hsin Chu, Shou-Chuan Shih, Tsang-En Wang
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 32, Iss 1, Pp 10-15 (2016)
Lamivudine, telbivudine, and entecavir are the first-line drugs covered by the Taiwan National Health Insurance as 3-year treatments for patients with chronic hepatitis B virus (HBV), but the optimal treatment duration of each remains unclear. We aim
Externí odkaz:
https://doaj.org/article/cf4bf80647bd4525a5b56c766ec1e69d
Autor:
Jyh-Ming Liou, Chi-Yang Chang, Mei-Jyh Chen, Chieh-Chang Chen, Yu-Jen Fang, Ji-Yuh Lee, Jeng-Yih Wu, Jiing-Chyuan Luo, Tai-Cherng Liou, Wen-Hsiung Chang, Cheng-Hao Tseng, Chun-Ying Wu, Tsung-Hua Yang, Chun-Chao Chang, Hsiu-Po Wang, Bor-Shyang Sheu, Jaw-Town Lin, Ming-Jong Bair, Ming-Shiang Wu, Taiwan Gastrointestinal Disease and Helicobacter Consortium
Publikováno v:
PLoS ONE, Vol 10, Iss 5, p e0124199 (2015)
The Taiwan Government issued a policy to restrict antimicrobial usage since 2001. We aimed to assess the changes in the antibiotic consumption and the primary resistance of H. pylori after this policy and the impact of virulence factors on resistance
Externí odkaz:
https://doaj.org/article/4ef9207d49fd4b2594f2f3835f0e1dd5
Autor:
Cheng-Jui Lin, Tai-Cherng Liou, Chi-Feng Pan, Pei-Chen Wu, Fang-Ju Sun, Hsuan-Liang Liu, Han-Hsiang Chen, Chih-Jen Wu
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0134590 (2015)
Evidence has shown that indoxyl sulfate (IS) and p-cresyl sulfate (PCS) may be alternative predictors of clinical outcomes in chronic kidney disease (CKD). Both toxins are derived from the gastrointestinal tract and metabolised in the liver. However,
Externí odkaz:
https://doaj.org/article/06f64f1970af44d680d3e52cc36d732a
Autor:
Cheng-Yu, Ho, Ting-Wen, Liu, Yang-Sheng, Lin, Yen-Po, Chen, Ming-Jen, Chen, Horng-Yuan, Wang, Tai-Cherng, Liou
Publikováno v:
Microorganisms. 10(2)
Publikováno v:
Journal of Gastroenterology and Hepatology. 34:1337-1343
Background and aim Several strategies have been proposed to increase the eradication rate of Helicobacter pylori. However, the widespread increasing resistance rates to current multiple-dose oral antibiotic therapies call for alternative therapeutic
Autor:
Yu-Chio, Wang, Yen-Po, Chen, Cheng-Yu, Ho, Ting-Wen, Liu, Cheng-Hsin, Chu, Horng-Yuan, Wang, Tai-Cherng, Liou
Publikováno v:
Journal of Clinical Medicine
Background: Helicobacter pylori (H. pylori) can be topically eradicated in stomach lumen on endoscopic examination. The procedures of intraluminal therapy for H. pylori infection (ILTHPI) include the control of intragastric pH, mucolytic irrigation o
Publikováno v:
JGH Open. 2:93-96
Background and aim To assess the detection rates of Helicobacter pylori colonization in the gastric cardia with two commercial kits of rapid urease test: 5 min UFT300 and 24 h CLO test in H. pylori-infected patients. Methods Eighty consecutive dyspep
Autor:
Cheng-Hsin Chu, Shou-Chuan Shih, Chia-Yuan Liu, Chen-Wang Chang, Ming-Jong Bair, Chih-Jen Chen, Tsang-En Wang, Ching-Chung Lin, Shee-Chan Lin, Keng-Han Lee, Kuang-Chun Hu, Horng-Yuan Wang, Ming-Jen Chen, Tai-Cherng Liou
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 32, Iss 1, Pp 10-15 (2016)
Lamivudine, telbivudine, and entecavir are the first-line drugs covered by the Taiwan National Health Insurance as 3-year treatments for patients with chronic hepatitis B virus (HBV), but the optimal treatment duration of each remains unclear. We aim